Home » Newsletters » BioWorld

BioWorld

April 16, 1992

View Archived Issues

BETA-AMYLOID PROTEIN LINKED TO BRAIN DAMAGE

ELAN BOOSTED AGAIN BY ANNOUNCEMENTS

NEW SUCCESS WITH MYOBLAST GENE THERAPY

GENE THERAPY FOR BRAIN DISEASE

IMMUNOGEN STARTS EUROPEAN TRIALS

IMMURAID GETS ORPHAN DESIGNATION

SEPRACOR PATENT COVERS PROZAC ISOMER

FDA DEMANDS NEW TRIAL FOR CENTOXIN

BIOTECH SELL-OFF: BAD, BUT NOT TERRIBLE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...